Overview

Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study is to evaluate the efficacy of sodium bicarbonate plus N-acetylcysteine for the prevention of contrast-induced nephropathy.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Osaka General Medical Center
Treatments:
Acetylcysteine
N-monoacetylcystine
Criteria
Inclusion Criteria:

- patients with chronic renal failure(serum creatinine >1.1mg/dl) undergoing elective
percutaneous coronary intervention

Exclusion Criteria:

- administered with sodium bicarbonate and/or N-acetylcysteine and/or contrast media
within 72 hours.

- pregnancy

- congestive heart failure

- allergy to sodium bicarbonate and/or N-acetylcysteine

- hemodialysis